Economic evaluation of lymphaticovenous anastomosis versus conservative therapy for breast cancer-related lymphoedema: secondary outcome analysis of a randomized clinical trial
British Journal of Surgery · 2026
DOI: 10.1093/bjs/znag062 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Surgery, 2026. Verfasst von Alieske Kleeven und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic, Reconstructive, and Hand Surgery, Maastricht University Medical Centre+, Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Lymphatic Vessels, Breast Cancer Lymphedema, Conservative Treatment, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw, Maastricht University Medical Centre.
Abstract (Originalsprache)
Background
Lymphaticovenous anastomosis (LVA) is an increasingly applied microsurgical option for lymphoedema. The aim of this study was to evaluate the cost-effectiveness of LVA combined with complex decongestive therapy (CDT) versus CDT alone for breast cancer-related lymphoedema (BCRL).
Methods
A cost-effectiveness analysis was performed as a pre-specified secondary outcome of an RCT comparing LVA combined with CDT versus CDT alone. The primary outcome of the trial was health-related quality of life (HRQoL). A societal perspective with a 2-year time horizon was adopted. Quality-adjusted life-years (QALYs) were derived from the EuroQol five-dimension, five-level (EQ-5D-5L) questionnaire. Uncertainty was assessed using bootstrapping and sensitivity analysis. Data were collected from four Dutch hospitals. The primary outcome was the incremental cost-effectiveness ratio (ICER).
Results
One hundred female patients were included (mean age 58.5 years). Over 2 years, mean total costs were €16 234 (LVA) versus €14 293 (CDT); adjusted mean difference €78 (95% c.i. −€6044 to €6200). Mean(s.e.) QALYs were 1.636(0.003) (LVA) versus 1.579(0.002) (CDT); adjusted mean difference 0.045 (95% c.i. −0.021 to 0.112). The ICER from a societal perspective was €1716/QALY, with probabilities of cost-effectiveness of 0.60 and 0.71 at the €20 000 and €50 000 willingness-to-pay thresholds respectively. From a healthcare perspective, the ICER was €59 679/QALY, with probabilities of cost-effectiveness of 0.08 and 0.42 at the same thresholds respectively.
Conclusion
LVA combined with CDT was more costly than CDT alone, but societal costs were limited during the 2-year follow-up interval. The LVA group acquired slightly more QALYs. From a societal perspective, LVA combined with CDT has the potential to be cost-effective, particularly when performed under local anaesthesia. Registration number NCT02790021 (http://www.clinicaltrials.gov).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Plastic, Reconstructive, and Hand Surgery, Maastricht University Medical Centre+, Maastricht, The Netherlands.
- Department of Plastic Surgery, Radboud University Medical Centre, Nijmegen, The Netherlands.
- GROW, School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
- Faculty of Health, Medicine, and Life Sciences, Maastricht University, Maastricht, The Netherlands.
- Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.
ORCID-Profile: Stefan Hummelink, Shan Shan Qiu
Förderung
- ZonMw
- Maastricht University Medical Centre
Zitieren
APA
Kleeven, A., Jonis, Y. M. J., Currie, O., Wolfs, J., Kimman, M., Tielemans, H., van der Hulst, R. R. W. J., Hummelink, S., & Qiu, S. S. (2026). Economic evaluation of lymphaticovenous anastomosis versus conservative therapy for breast cancer-related lymphoedema: secondary outcome analysis of a randomized clinical trial. British Journal of Surgery. https://doi.org/10.1093/bjs/znag062
Vancouver
Kleeven A, Jonis YMJ, Currie O, Wolfs J, Kimman M, Tielemans H, et al. Economic evaluation of lymphaticovenous anastomosis versus conservative therapy for breast cancer-related lymphoedema: secondary outcome analysis of a randomized clinical trial. British Journal of Surgery. 2026. doi:10.1093/bjs/znag062
BibTeX
@article{Kleeven2026,
author = {Kleeven, Alieske and Jonis, Yasmine M J and Currie, Olivia and Wolfs, Joost and Kimman, Merel and Tielemans, Hanneke and van der Hulst, René R W J and Hummelink, Stefan and Qiu, Shan Shan},
title = {Economic evaluation of lymphaticovenous anastomosis versus conservative therapy for breast cancer-related lymphoedema: secondary outcome analysis of a randomized clinical trial},
journal = {British Journal of Surgery},
year = {2026},
doi = {10.1093/bjs/znag062}
}
EUVIMED